MCRB logo
MCRB NASDAQ US

Seres Therapeutics, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Jun 2015
$9.27
▲ +$0.41 (+4.63%)
Vol 77K
9
Quality Score
ok
Deep Check
1/5 fail
Mkt Cap
$134.6M
P/E
25.0
ROE
15.3%
Margin
2337.3%
D/E
0.00
Beta
0.19
52W
$7–$30

Wall Street Consensus

7 analysts · Apr 2026
2
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Similar Stocks

COYA
Coya Therapeutics Inc
$121.4M
QTTB
Q32 Bio Inc
$40.9M
PYXS
Pyxis Oncology Inc
$71.6M
RCEL
AVITA Medical Inc
$105.2M
GOSS
Gossamer Bio Inc
$717.5M
HURA
TuHURA Biosciences Inc
$45.9M
ANIX
Anixa Biosciences Inc
$102.7M
ATYR
aTyr Pharma Inc
$76.7M
FBIO
Fortress Biotech Inc
P/E 28.5
$113.6M

Earnings

Beat rate: 50.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-2.15 $-1.78 +$0.37
Sep 2025 $1.31 $0.94 $-0.37
Jun 2025 $-2.54 $-2.27 +$0.27
Mar 2025 $-0.55 $-2.96 $-2.41

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) 283.9% 388.0% 388.0% 388.0% 15.3% 15.3%
P/E (TTM) 1.13 1142.60 1335.72 1036.39 28.01 24.96
Net Margin — -10.3% -10.3% -10.3% 2337.3% 2337.3%
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 1.57 1.57 1.57 1.57 2.30 2.30

Key Ratios

ROA (TTM)
3.7%
P/S (TTM)
383.51
P/B
10.3
EPS (TTM)
$2.32
CF/Share
$-1.06
Rev Growth 3Y
+72.4%
52W High
$29.98
52W Low
$6.53
$6.53 52-Week Range $29.98

How does MCRB compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

MCRB AAPG ABEO ABOS ABP

MCRB valuation vs Biotechnology peers

P/E ratio
25.0
▲ 33% above peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
383.5
▲ 2885% above peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
10.3
▲ 318% above peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

MCRB profitability vs Biotechnology peers

ROE
15.3%
▲ 123% above peers (-67.3%)
vs Peers
vs Industry
Top tier
Net margin
2337.3%
▲ 915% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
3.7%
▲ 108% above peers (-46.7%)
vs Peers
vs Industry
Top tier

MCRB financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
2.3
▼ 48% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.2
▼ 80% below peers (1.0)
vs Peers
vs Industry
More volatile

MCRB fundamentals radar

MCRB Peer median Industry

MCRB profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

MCRB vs peers: key metrics

Latest News

No related news yet